Track whether the sale actually executes, large insider selling by a former officer over two months may signal reduced conviction or planned diversification. Monitor for any material non-public catalysts (upcoming data readouts, guidance updates). Consider the selling into the current bullish analyst consensus (65% buy) as a potential contrarian signal.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Jul 1 $36.00entry
- T+1 · 5mo ago +3.50%α +3.63% · $37.26
- T+5 · 4mo ago +6.28%α +6.02% · $38.26
- T+20 · 4mo ago −0.39%α +1.80% · $35.86
- T+60 · due 8w ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Former officer Sandip Kapadia filed a Form 144 notice to sell 50,000 shares of Harmony Biosciences, valued at approximately $1.8M. This follows a string of recent sales by Kapadia in May and June 2026 totaling approximately $4.5M, raising concerns about insider conviction ahead of potential catalysts.
Key Facts
- Former officer Sandip Kapadia filed Form 144 to sell 50,000 shares valued at ~$1.8M.
- Kapadia executed prior sales: 45,594 shares on 06/26 (~$1.6M), 4,406 on 06/24 (~$0.15M), 27,960 on 06/09 (~$0.94M), 2,101 on 06/05 (~$0.07M), 7,064 on 06/04 (~$0.23M), and 45,481 on 05/08 (~$1.43M).
- Total recent sales by this insider exceed $4.5M in aggregate.
- The proposed sale is for 50,000 shares (no remaining holdings disclosed in filing).
- HRMY market cap is $2.1B; the proposed block is ~0.09% of market cap.
Financial Impact
Proposed sale of 50,000 shares valued at ~$1.8M, plus ~$4.5M in prior sales since May 2026, total insider cash-out ~$6.3M.
Risk Factors
- Form 144 is intent to sell, execution is not guaranteed.
- Insider may have tax or estate-planning motives unrelated to company outlook.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006634 |
| Document: 0001950047-26-006634-index.html | 0001950047-26-006634 |
| Document: 0001950047-26-006634.txt | 0001950047-26-006634 |
Track record
20 reports on HRMY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $33.21 Now $32.96 −0.75% settles Dec 15
- Nov 4, 202612d ago 8-K Bearish 5/10 No price data
- Nov 4, 202612d ago Press Release Bearish 5/10 Entry $34.42 Now $32.96 +4.23% settles Dec 3
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $37.02 Now $32.96 −10.97% settles Dec 2
- Oct 30, 202617d ago 8-K/A Neutral 3/10 Entry $37.91 Now $32.96 −13.06% settles Dec 1
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $38.50 Now $32.96 −14.39% settles Nov 25
- Oct 13, 20264w ago 8-K Neutral 3/10 Entry $37.03 to $33.55 Now $32.96 −10.99% ▼ −9.40% −5.79% vs SPY
- Oct 1, 20266w ago Press Release Neutral 3/10 Entry $39.57 to $38.59 Now $32.96 −16.70% ▼ −2.48% −3.18% vs SPY
- Aug 4, 202614w ago 8-K Bullish 7/10 No price data
- Aug 4, 202614w ago Press Release Bullish 6/10 Entry $38.78 Now $32.96 −15.01% No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers